OCULAR THERAPEUTIX
Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.
OCULAR THERAPEUTIX
Industry:
Biotechnology Health Care Medical Device
Founded:
2006-01-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.ocutx.com
Total Employee:
51+
Status:
Active
Contact:
(781)357-4000
Email Addresses:
[email protected]
Total Funding:
271.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sparta Group
Sparta Group investment in Series D - Ocular Therapeutix
Dan Burgess
Dan Burgess investment in Series D - Ocular Therapeutix
Versant Ventures
Versant Ventures investment in Series D - Ocular Therapeutix
Ascension Ventures
Ascension Ventures investment in Series D - Ocular Therapeutix
Polaris Venture Capital
Polaris Venture Capital investment in Series D - Ocular Therapeutix
Baxter International
Baxter International investment in Series D - Ocular Therapeutix
Polaris Partners
Polaris Partners investment in Series D - Ocular Therapeutix
Versant Ventures
Versant Ventures investment in Series D - Ocular Therapeutix
Ascension Ventures
Ascension Ventures investment in Series D - Ocular Therapeutix
SV Health Investors
SV Health Investors investment in Series D - Ocular Therapeutix
Key Employee Changes
Date | New article |
---|---|
2021-09-28 | Ocular Therapeutixโข Announces Appointment of Karen-Leigh Edwards as Senior Vice President of Technical Operations |
Official Site Inspections
http://www.ocutx.com Semrush global rank: 275.99 K Semrush visits lastest month: 240.75 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago